PMAM
JAZZ icon

Picton Mahoney Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Picton Mahoney Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08K Sell
11
-1,450
-99% -$253K ﹤0.01% 1023
2025
Q4 		$248K Buy
1,461
+1,450
+13,182% +$222K ﹤0.01% 790
2025
Q3 		$1K Hold
11
– – ﹤0.01% 951
2025
Q2 		$1K Sell
11
-269
-96% -$29.2K ﹤0.01% 835
2025
Q1 		$34K Buy
280
+269
+2,445% +$35.1K ﹤0.01% 479
2024
Q4 		$1K Sell
11
-95
-90% -$11.2K ﹤0.01% 711
2024
Q3 		$11K Buy
+106
New +$11.6K ﹤0.01% 519
2023
Q3 		– Sell
-635
Closed -$79K – 451
2023
Q2 		$79K Sell
635
-20
-3% -$2.69K ﹤0.01% 320
2023
Q1 		$96K Sell
655
-210
-24% -$31.1K ﹤0.01% 371
2022
Q4 		$138K Sell
865
-55
-6% -$8.06K 0.01% 514
2022
Q3 		$122K Sell
920
-100
-10% -$15.2K ﹤0.01% 546
2022
Q2 		$159K Sell
1,020
-965
-49% -$149K 0.01% 628
2022
Q1 		$309K Sell
1,985
-4,635
-70% -$673K 0.01% 639
2021
Q4 		$843K Sell
6,620
-27,320
-80% -$3.59M 0.02% 615
2021
Q3 		$4.42M Sell
33,940
-1,320
-4% -$199K 0.16% 139
2021
Q2 		$6.26M Buy
35,260
+690
+2% +$120K 0.18% 105
2021
Q1 		$5.68M Sell
34,570
-8,360
-19% -$1.38M 0.27% 107
2020
Q4 		$7.09M Buy
+42,930
New +$6.39M 0.34% 92

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Picton Mahoney Asset Management's JAZZ Position: Q1 2026 in Review

Picton Mahoney Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 99% in Q1 2026, selling an estimated $253K and leaving 11 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Picton Mahoney Asset Management first reported a position in JAZZ in Q4 2020 and has held it in 18 quarters since. The position peaked at $7.09M in Q4 2020. 572 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Picton Mahoney Asset Management held 11 shares of Jazz Pharmaceuticals worth $2.08K as of Q1 2026.
  • Picton Mahoney Asset Management sold 1,450 Jazz Pharmaceuticals shares in Q1 2026, an estimated $253K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #1023 holding.
  • Picton Mahoney Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • Picton Mahoney Asset Management's Jazz Pharmaceuticals position peaked at $7.09M in Q4 2020.
  • 572 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.